Total Payments
$55,627
2024 Payments
$39.06
Companies
12
Transactions
39
Medicare Patients
2,873
Medicare Billing
$238,506
Payment Breakdown by Category
Research$49,656 (89.3%)
Other$2,652 (4.8%)
Food & Beverage$1,694 (3.0%)
Travel$1,625 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $49,656 | 2 | 89.3% |
| Honoraria | $2,500 | 1 | 4.5% |
| Food and Beverage | $1,694 | 31 | 3.0% |
| Travel and Lodging | $1,625 | 4 | 2.9% |
| Entertainment | $151.86 | 1 | 0.3% |
Payments by Type
Research
$49,656
2 transactions
General
$5,971
37 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Resmed Corp | $49,808 | 3 | $0 (2017) |
| ADVANCED RESPIRATORY, INC | $2,721 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $1,635 | 7 | $0 (2019) |
| Fisher & Paykel Healthcare Inc | $739.52 | 7 | $0 (2020) |
| Philips Electronics North America Corporation | $239.87 | 3 | $0 (2019) |
| Biogen, Inc. | $122.03 | 1 | $0 (2018) |
| GENZYME CORPORATION | $96.13 | 1 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $95.04 | 5 | $0 (2019) |
| Hill-Rom Company, Inc | $78.10 | 2 | $0 (2019) |
| Philips North America LLC | $39.06 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.06 | 1 | Philips North America LLC ($39.06) |
| 2022 | $17.74 | 1 | OptiNose US, Inc. ($17.74) |
| 2020 | $321.28 | 4 | Fisher & Paykel Healthcare Inc ($321.28) |
| 2019 | $2,099 | 20 | Merck Sharp & Dohme Corporation ($1,635) |
| 2018 | $2,877 | 7 | Advanced Respiratory, Inc ($2,601) |
| 2017 | $50,273 | 6 | Resmed Corp ($49,808) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $39.06 | General |
| Category: Medical Device | ||||||
| 10/03/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 03/12/2020 | Fisher & Paykel Healthcare Inc | Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: Respiratory | ||||||
| 03/11/2020 | Fisher & Paykel Healthcare Inc | Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) | Food and Beverage | In-kind items and services | $77.73 | General |
| Category: Respiratory | ||||||
| 03/11/2020 | Fisher & Paykel Healthcare Inc | Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: Respiratory | ||||||
| 03/10/2020 | Fisher & Paykel Healthcare Inc | Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) | Food and Beverage | In-kind items and services | $205.74 | General |
| Category: Respiratory | ||||||
| 12/06/2019 | ADVANCED RESPIRATORY, INC | The MetaNeb System (Device) | Food and Beverage | In-kind items and services | $46.96 | General |
| Category: Airway Clearance Device | ||||||
| 11/01/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2019 | Hill-Rom Company, Inc | The MetaNeb System (Device) | Food and Beverage | In-kind items and services | $38.95 | General |
| Category: Airway Clearance Device | ||||||
| 10/08/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $10.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $99.30 | General |
| 09/13/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $61.20 | General |
| 09/13/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $48.75 | General |
| 09/13/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $46.12 | General |
| 09/12/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $1,044.36 | General |
| 09/12/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $231.56 | General |
| 09/12/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $103.25 | General |
| 07/24/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: RESPIRATORY | ||||||
| 06/25/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2019 | GENZYME CORPORATION | LUMIZYME (Drug) | Food and Beverage | In-kind items and services | $96.13 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 06/10/2019 | Philips Electronics North America Corporation | Mask (Device), NightBalance Und | Food and Beverage | Cash or cash equivalent | $115.00 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 05/22/2019 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Respiratory | ||||||
| 03/16/2019 | Fisher & Paykel Healthcare Inc | Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Respiratory | ||||||
| 02/27/2019 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Respiratory | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Astral iVAPS AutoEPAP | Resmed Corp | $49,656 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 938 | 1,002 | $284,654 | $62,787 |
| 2022 | 12 | 572 | 636 | $221,022 | $53,442 |
| 2021 | 15 | 790 | 875 | $267,801 | $65,624 |
| 2020 | 12 | 573 | 666 | $234,382 | $56,654 |
Total Patients
2,873
Total Services
3,179
Medicare Billing
$238,506
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 188 | 238 | $103,292 | $33,615 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $21,276 | $5,139 | 24.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 45 | $22,380 | $4,978 | 22.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 30 | 32 | $8,000 | $2,999 | 37.5% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Facility | 2023 | 85 | 87 | $28,710 | $2,854 | 9.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 25 | 25 | $22,800 | $2,450 | 10.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 25 | 25 | $24,475 | $2,446 | 10.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 34 | $7,402 | $2,250 | 30.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 53 | 59 | $11,033 | $1,246 | 11.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 111 | 111 | $7,437 | $1,060 | 14.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 124 | 124 | $5,580 | $891.60 | 16.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 18 | 18 | $5,796 | $801.30 | 13.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 93 | 93 | $4,650 | $612.32 | 13.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 14 | 14 | $4,634 | $537.74 | 11.6% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 17 | 17 | $3,383 | $516.96 | 15.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 33 | 33 | $3,069 | $281.49 | 9.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 11 | 11 | $737.00 | $109.01 | 14.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 163 | 214 | $92,876 | $30,996 | 33.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 48 | 49 | $12,250 | $4,963 | 40.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $16,204 | $3,633 | 22.4% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Facility | 2022 | 68 | 69 | $22,770 | $2,347 | 10.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 25 | 25 | $22,800 | $2,319 | 10.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $7,500 | $2,034 | 27.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 18 | 19 | $18,601 | $1,988 | 10.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 16 | $7,329 | $1,905 | 26.0% |
About Dr. Lisa Wolfe, MD
Dr. Lisa Wolfe, MD is a Pulmonary Disease healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336166800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lisa Wolfe, MD has received a total of $55,627 in payments from pharmaceutical and medical device companies, with $39.06 received in 2024. These payments were reported across 39 transactions from 12 companies. The most common payment nature is "" ($49,656).
As a Medicare-enrolled provider, Wolfe has provided services to 2,873 Medicare beneficiaries, totaling 3,179 services with total Medicare billing of $238,506. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Chicago, IL
- Active Since 07/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1336166800
Products in Payments
- Astral (Device) $49,656
- The MetaNeb System (Device) $2,726
- Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) $346.92
- ApneaLink (Device) $151.86
- SPINRAZA (Biological) $122.03
- Mask (Device) $115.00
- CPAP Service Sales (Device) $114.30
- LUMIZYME (Drug) $96.13
- Vest 205 Metaneb System (Device) $72.43
- LONHALA MAGNAIR (Drug) $59.76
- (AK6) Vest Therapy (Device) $39.06
- TRELEGY ELLIPTA (Drug) $36.07
- BROVANA (Drug) $35.28
- Xhance (Drug) $17.74
- inCourage (Device) $10.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Chicago
Douglas Hogarth
Pulmonary Disease — Payments: $3.0M
Pulmonary Disease $3.0M
Septimiu Murgu
Pulmonary Disease — Payments: $1.0M
Pulmonary Disease $1.0M
Steven White
Pulmonary Disease — Payments: $685,389
Pulmonary Disease $685,389
Ayodeji Adegunsoye
Pulmonary Disease — Payments: $504,729
Pulmonary Disease $504,729
Brian Garibaldi, M.d, M.D
Pulmonary Disease — Payments: $355,981
Pulmonary Disease $355,981
Dr. Ravi Kalhan, M.d, M.D
Pulmonary Disease — Payments: $327,619
Pulmonary Disease $327,619